Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
Abstract Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half‐lives, the typical duration used to guide pre‐operative medication recommendations.
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wiley
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/34c939d53002417eb7eb7864524bb8df |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|